Leerink Partnrs Equities Analysts Increase Earnings Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Leerink Partnrs boosted their Q2 2024 earnings per share estimates for shares of DENTSPLY SIRONA in a research report issued to clients and investors on Tuesday, July 9th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will post earnings per share of $0.50 for the quarter, up from their previous estimate of $0.49. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.02 per share.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The business had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm’s revenue was down 2.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.39 EPS.

XRAY has been the topic of several other research reports. The Goldman Sachs Group dropped their price target on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Monday, May 6th. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Barrington Research reiterated an “outperform” rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Evercore ISI reduced their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and an average target price of $34.33.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $25.53 on Friday. The company has a market capitalization of $5.30 billion, a PE ratio of -58.02, a PEG ratio of 1.09 and a beta of 1.01. DENTSPLY SIRONA has a 12 month low of $23.94 and a 12 month high of $41.65. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The stock’s fifty day simple moving average is $26.66 and its 200 day simple moving average is $31.06.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in XRAY. Graham Capital Management L.P. increased its holdings in shares of DENTSPLY SIRONA by 21.1% during the third quarter. Graham Capital Management L.P. now owns 30,753 shares of the medical instruments supplier’s stock worth $1,051,000 after buying an additional 5,366 shares in the last quarter. Deutsche Bank AG increased its holdings in shares of DENTSPLY SIRONA by 12.0% during the third quarter. Deutsche Bank AG now owns 771,684 shares of the medical instruments supplier’s stock worth $26,361,000 after buying an additional 82,840 shares in the last quarter. VisionPoint Advisory Group LLC increased its holdings in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of DENTSPLY SIRONA by 1.5% in the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock worth $862,555,000 after purchasing an additional 369,213 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $47,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 3,577 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the purchase, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.51%. The ex-dividend date was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.